- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 305964, 8 pages
Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma Samples in Pregnancies at Risk for Preeclampsia
1Department of Biomedicine, University Women’s Hospital, 4031 Basel, Switzerland
2Biozentrum, University of Basel, 4056 Basel, Switzerland
3Laboratory for Prenatal Medicine, Department of Biomedicine, University Women’s Hospital, Hebelstrasse 20, CH 4031 Basel, Switzerland
Received 31 May 2011; Revised 26 December 2011; Accepted 28 December 2011
Academic Editor: Saulius Butenas
Copyright © 2012 Varaprasad Kolla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [18 citations]
The following is the list of published articles that have cited the current article.
- Cristina Pop, Gianina C. Crisan, Felicia Loghin, and Cristina I. Mogosan, “Advances in the detection and quantification of candidate and established biomarkers in heart failure,” Revista Romana de Medicina de Laborator, vol. 21, no. 3-4, pp. 255–265, 2013.
- Jacqueline E. Siljee, Esther J. Wortelboer, Maria P. H. Koster, Sandra Imholz, Wendy Rodenburg, Gerard H. A. Visser, Annemieke de Vries, Peter C. J. I. Schielen, and Jeroen L. A. Pennings, “Identification of interleukin-1 beta, but no other inflammatory proteins, as an early onset pre-eclampsia biomarker in first trimester serum by bead-based multiplexed immunoassays,” Prenatal Diagnosis, pp. 1–6, 2013.
- Hyoung-Joo Lee, Seul-Ki Jeong, Keun Na, Min Jung Lee, Sun Hee Lee, Jong-Sun Lim, Hyun-Jeong Cha, Jin-Young Cho, Ja-Young Kwon, Hoguen Kim, Si Young Song, Jong Shin Yoo, Young Mok Park, Hail Kim, William S. Hancock, and Young-Ki Paik, “Comprehensive Genome-Wide Proteomic Analysis of Human Placental Tissue for the Chromosome-Centric Human Proteome Project,” Journal of Proteome Research, pp. 130214125341009, 2013.
- N.D. Avent, “Maternal plasma biomarkers for down syndrome: Present and future,” Drugs of Today, vol. 49, no. 2, pp. 145–152, 2013.
- Jianhua Zheng, Liguo Liu, Jin Wang, and Qi Jin, “Urinary proteomic and non-prefractionation quantitative phosphoproteomic analysis during pregnancy and non-pregnancy,” Bmc Genomics, vol. 14, 2013.
- Linda Y. Liu, Ting Yang, Jun Ji, Qiaojun Wen, Alexander A. Morgan, Bo Jin, Gongxing Chen, Deirdre J. Lyell, David K. Stevenson, Xuefeng B. Ling, and Atul J. Butte, “Integrating multiple 'omics' analyses identifies serological protein biomarkers for preeclampsia,” Bmc Medicine, vol. 11, 2013.
- Fuqiang Wang, Zhonghua Shi, Ping Wang, Wei You, and Gaolin Liang, “Comparative Proteome Profile of Human Placenta from Normal and Preeclamptic Pregnancies,” Plos One, vol. 8, no. 10, 2013.
- Peter von Dadelszen, and Laura A. Magee, “Pre-eclampsia: An Update,” Current Hypertension Reports, vol. 16, no. 8, 2014.
- Julie Klein, Benedicte Buffin-Meyer, William Mullen, David M. Carty, Christian Delles, Antonia Vlahou, Harald Mischak, Stephane Decramer, Jean-Loup Bascands, and Joost P. Schanstra, “Clinical proteomics in obstetrics and neonatology,” Expert Review of Proteomics, vol. 11, no. 1, pp. 75–89, 2014.
- G. H. Khan, N. Galazis, N. Docheva, R. Layfield, and W. Atiomo, “Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration,” Human Reproduction, 2014.
- Hao Chen, Lina Xu, Lianhong Yin, Youwei Xu, Xu Han, Yan Qi, Yanyan Zhao, Kexin Liu, and Jinyong Peng, “iTRAQ-based proteomic analysis of dioscin on human HCT-116 colon cancer cells,” Proteomics, vol. 14, no. 1, pp. 51–73, 2014.
- Xiaojuan Wang, Yani Li, Guanghui Xu, Muhan Liu, Lin Xue, Lijuan Liu, Sijun Hu, Ying Zhang, Yongzhan Nie, Shuhui Liang, Biaoluo Wang, and Jie Ding, “Mechanism study of peptide GMBP1 and its receptor GRP78 in modulating gastric cancer MDR by iTRAQ-based proteomic analysis,” BMC Cancer, vol. 15, no. 1, 2015.
- Kai P. Law, Ting-Li Han, Chao Tong, and Philip N. Baker, “Mass Spectrometry-Based Proteomics for Pre-Eclampsia and Preterm Birth,” International Journal Of Molecular Sciences, vol. 16, no. 5, pp. 10952–10985, 2015.
- Sinuhe Hahn, Olav Lapaire, and Nandor Gabor Than, “Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?,” Expert Review of Molecular Diagnostics, pp. 1–13, 2015.
- Malia Su-Qin Murphy, Egle Bytautiene, George Saade, and Graeme Neil Smith, “Alterations to the maternal circulating proteome after preeclampsia,” American Journal of Obstetrics and Gynecology, 2015.
- Aggeliki Kolialexi, Dimitrios Gourgiotis, George Daskalakis, Antonis Marmarinos, Alexandra Lykoudi, Danai Mavreli, Ariadni Mavrou, and Nikolas Papantoniou, “Validation of Serum Biomarkers Derived from Proteomic Analysis for the Early Screening of Preeclampsia,” Disease Markers, vol. 2015, pp. 1–7, 2015.
- Yamile Lopez-Hernandez, Jorge Alejandro Saldivar-Nava, Idalia Garza-Veloz, Ivan Delgado-Enciso, Laura Elia Martinez-de-Villarreal, Patricia Yahuaca-Mendoza, Iram Pablo Rodriguez-Sanchez, Laura Lopez-Gilibets, Jorge Issac Galvan-Tejada, Carlos Eric Galvan-Tejada, Jose Maria Celaya-Padilla, and Margarita L. Martinez-Fierro, “Nested case–control study reveals increased levels of urinary proteins from human kidney toxicity panels in women predicted to develop preeclampsia,” International Urology and Nephrology, 2016.
- Efser Oztas, Sibel Ozler, Ali Ozgur Ersoy, Can Tekin Iskender, Ayhan Sucak, Merve Ergin, Dilek Uygur, and Nuri Danisman, “Increased levels of serum clusterin is associated with intrauterine growth restriction and adverse pregnancy outcomes in preeclampsia,” Journal Of Perinatal Medicine, vol. 44, no. 3, pp. 269–275, 2016.